ABSTRACT
Phlegm syndrome, as the main syndrome of coronary heart diseases, not only its clinical signs and symptoms are clear, but also related with gene polymorphism, plasma metabolomics, genomics protein metabolism and urine metabolomics indicators, especially the close connection between serum lipids and phlegm syndrome in coronary heart diseases. The further research on the connection can be used as the references for the syndrome diagnosis and clinical treatment guidance, and provide solid foundation for TCM syndromes toward internationalization. This article pointed out that the treatment of coronary heart diseases should retain Chinese characteristics, focus on the basis of the phlegm syndrome, and pay attention to control lipid levels, in order to improve the clinical efficacy, and look forward to making progress in in-depth study on efficacy evaluation system of phlegm syndrome in coronary heart diseases.
ABSTRACT
Objective To test the degree of acceptance and understanding of the entries for patient reported outcomes of stagnation of qi and blood;To further optimize and modify the entries. Methods A small sample pre-survey and group interviews were used to get the feedback information abut entries of patients, then the panel discussed to modify entries according to the data information. Results After a small sample pre-survey and group interviews, 11 items for modification were obtained, including the rejection in physical pain, belching and so on. Through further optimization and modification, the entries for patient reported outcomes of stagnation of qi and blood covered 41 entries in physiological domain, 11 entries in psychological domain, 1 entry in independent domain, and 8 entries in social domain. Conclusion The core part of the entries for patient reported outcomes of stagnation of qi and blood was formed, which comprehensively reflects the connotation of stagnation syndrome of qi and blood.